Archives
-
mCherry mRNA for Kidney Nanoparticle Workflows
2026-09-29
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) provides a practical red fluorescence readout for comparing nanoparticle loading, cellular uptake, and functional translation. This guide connects its Cap 1, modified-nucleotide design with the excipient-screening strategy reported in a kidney-targeted mesoscale nanoparticle study.
-
PKM2–Smad7 Control of Pulmonary Fibrosis
2026-09-28
Gao et al. show that tetrameric PKM2 promotes pulmonary fibrosis by binding Smad7, reducing Smad7-dependent TβR1 ubiquitination, and sustaining TGF-β1 signaling. The study links PKM2 metabolic-state regulation to receptor stability and provides genetic, biochemical, and pharmacological evidence for this mechanism in bleomycin-induced fibrosis.
-
Nitroaromatic Nannocystin 4 Targets AKT1 in CRC
2026-09-28
The study reports the synthesis of a nitroaromatic nannocystin, compound 4, and evaluates its activity from colorectal cancer cell lines and patient-derived organoids to a xenograft model. The evidence supports potent antitumor activity and implicates AKT1 as one contributor to the response, while leaving questions about selectivity, mechanism, and broader translational relevance for further study.
-
Engineering DNA Polymerase for Large RNA Modification
2026-09-27
The PORDVA method uses an engineered Taq DNA polymerase variant to install diverse chemical modifications at selected positions in RNA, including messenger RNAs up to 1,800 nucleotides long. The study reports high incorporation efficiencies for several modification classes and shows that selected modifications can influence mRNA stability and protein output, while leaving important questions about broader substrate compatibility and biological performance for future testing.
-
EZ Cap™ Mouse IL-7 mRNA: Evidence & Use
2026-09-26
EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) is identified as APExBIO product R1054, but the supplied product dossier does not provide sequence, formulation, or application-specific parameters. This article separates established IL-7 and modified-mRNA biology from product-specific details that require confirmation.
-
Self-Assembling EVMPs Target Extrahepatic mRNA Delivery
2026-09-25
The study introduces a modular, self-assembling enveloped virus-mimicking particle (EVMP) designed to deliver mRNA beyond the liver. By engineering the peptide assembly module and envelope phospholipids, the researchers report lung and spleen targeting, including substantial transfection across lung cell populations and suppression of metastatic lung tumor progression with IL-12 mRNA.
-
Golgi-Tracker Green: Reading Golgi Stress in Live Cells
2026-09-25
Golgi-Tracker Green enables live-cell Golgi apparatus imaging with a BODIPY FL-labeled C5-ceramide probe. This article explains how to interpret Golgi morphology during cellular stress, and how recent breast cancer research informs—but does not validate—such assays.
-
HyperScribe mRNA Kit for Viability Assays
2026-09-24
A practical guide to controlling mRNA-related variability in cell viability, proliferation, and cytotoxicity experiments. It explains what is—and is not—established for HyperScribe™ All in One mRNA Synthesis Kit II Plus 2, SKU K1068, and how to evaluate it without treating formulation details as performance data.
-
Intravesical p21 mRNA: From Mechanism to Translation
2026-09-24
A translational perspective on p21 mRNA–LNP therapy for bladder cancer: what the preclinical evidence establishes, why localized delivery matters, and how researchers can make disciplined choices in the upstream IVT workflow.
-
EGFP mRNA m1Ψ for Reporter Delivery Workflows
2026-09-23
Use EGFP mRNA m1Ψ to compare reporter delivery and expression across transfection conditions with a direct fluorescence readout. A practical workflow pairs dose and timing screens with viability checks—and keeps LNP storage findings in their proper formulation-specific context.
-
Chuanxiong Cortex vs Pith: Fenipentol and CHD
2026-09-23
The reference study combines SPME-GC×GC-MS, network pharmacology, and molecular docking to distinguish volatile constituents and coronary heart disease-related mechanisms in the cortex and pith of Ligusticum chuanxiong. Its identification of Fenipentol among the principal cortex-associated candidates supports part-specific pharmacological investigation while emphasizing that computational targets require experimental validation.
-
CA800-PR and Golgi Stress in HR+ Breast Cancer
2026-09-22
A study in Theranostics describes CA800-PR, a tumor-targeted heptamethine cyanine dye that suppresses progesterone receptor protein expression while inducing Golgi fragmentation, apoptosis, and immune-associated antitumor responses in hormone receptor-positive breast cancer models. The findings position CA800-PR as a multifunctional investigational strategy that differs from conventional endocrine therapy by combining tumor targeting, near-infrared imaging, and direct cytotoxic activity.
-
N4-Acetylcytidine Improves mRNA Translation Fidelity
2026-09-22
The reference study identifies N4-acetylcytidine (ac4C) as a functionally distinct alternative to m1Ψ for synthetic mRNA. By linking ribosome elongation, collision-dependent quality control, and translational fidelity to protein output, it shows why modified-nucleotide selection must be evaluated beyond immunogenicity and transcript stability.
-
K1068 mRNA Synthesis Kit for CAR mRNA
2026-09-21
The K1068 mRNA synthesis kit combines T7 transcription, EZ Cap Reagent AG with 3′ OMe, 5-moUTP, and poly(A) components in one product designation. The cited mouse study supports CD19 CAR mRNA as an in vivo CAR-T research strategy, but it does not validate K1068 itself or establish human clinical efficacy.
-
Apigenin Workflows for HDAC and Neuroprotection
2026-09-21
Apigenin supports a practical, mechanism-resolved workflow that links malignant mesothelioma cell growth inhibition with HDAC, apoptosis, ROS, and DNA-damage readouts. The same compound can be evaluated in neuroinflammation models, provided researchers separate published evidence from exploratory cross-domain assay design.